How concerned should we be about missing antibodies to low incidence antigens?

Transfusion

Volumn 43, Issue 7, 2003, Pages 844-847

  Garratty, George ^a  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; BIOCOMPATIBILITY; BLOOD TRANSFUSION REACTION; COST BENEFIT ANALYSIS; EDITORIAL; NEWBORN HEMOLYTIC DISEASE; SCREENING;

BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; FALSE NEGATIVE REACTIONS; HUMANS; ISOANTIBODIES; ISOANTIGENS;

EID: 0038307236     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00492.x     Document Type: Editorial

References (26)

1. Mintz PD, Nordine RB, Henry JB, et al. Expected hemotherapy in elective surgery. N Y State J Med 1976;76:532-7.
2. Friedman BA, Oberman HA, Chadwick AR, et al. The maximum surgical blood order schedule and surgical blood use in the United States. Transfusion 1976;16:380-7.
3. Boral LI, Henry JB. The type and screen: a safe alternative and supplement in selected surgical procedures. Transfusion 1977;17:163-8.
4. Beck ML, Tilzer LL. Red cell compatibility testing: a perspective for the future. Transfus Med Rev 1996;10:118-30.
5. Garratty G. The role of compatibility tests. Transfusion 1982;22:169-72.
6. Garratty G. Screening for RBC antibodies - what should we expect from antibody detection RBCs. Immunohematology 2002;18:71-7.
7. Boral LI, Hill SS, Apollon CJ, et al. The type and antibody screen, revisited. Am J Clin Pathol 1979;71:578-81.
8. Oberman HA, Barnes BA, Friedman BA. The risk of abbreviating the major crossmatch in urgent or massive transfusion. Transfusion 1978;18:137-41.
9. Oberman HA. Abbreviation or elimination of the crossmatch. Clin Lab Med 1982;2:181-92.
10. Lown JAG, Barr AL, Jackson JM. A reappraisal of pretransfusion testing procedures in a hospital blood bank. Pathology 1985;17:489-92.
11. Mintz D, Haines AL, Sullivan MF. Incompatible crossmatch following nonreactive antibody detection test. Transfusion 1982;22:107-10.
12. Shulman IA, Nelson JM, Saxena S, et al. Experience with the routine use of an abbreviated crossmatch. Am J Clin Pathol 1984;82:178-81.
13. Judd WJ. Commentary: testing for unexpected red cell antibodies - two or three reagent red cell samples? Immunohematology 1997;13:90-3.
14. Walker RH. On the safety of the abbreviated crossmatch. In: Polesky, HF, Walker, RH, eds. Safety in Transfusion Practices. Skokie, IL: College of American Pathologists, 1982:71-105.
15. Shulman IA. The risk of an overt hemolytic transfusion reaction following the use of an immediate spin crossmatch. Arch Pathol Lab Med 1990;114:412-4.
16. Issitt PD, Anstee DJ. Applied blood group serology, 4th edn. Durham, NC: Montgomery Scientific Publications, 1998.
17. a" in Taiwan. Transfusion 1994;34:349-52.
18. Lin CK, Mak KH, Cheng G, et al. Serologic characteristics and clinical significance of Miltenberger antibodies among Chinese patients in Hong Kong. Vox Sang 1998;74:59-60.
19. a". Transfusion 1994;34:1013.
20. Knowles SM, Milkins CE, Chapman JF, et al. The United Kingdom National External Quality Assessment Scheme (Blood Transfusion Laboratory Practice): trends in proficiency and practice between 1985 and 2000. Transfus Med 2002;12:11-23.
21. Vamvakas EC, Pineda AA, Reisner R, et al. The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis. Transfusion 1995;35:26-32.
22. Pineda AA, Vamvakas EC, Gorden LD, et al. Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion 1999;39:1097-103.
23. Rouger PH. International Forum. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel? Vox Sang 1982;43:151-68.
24. De la Rubia J, Sempere A, Arriaga F, et al. Safety of the antibody screening test as the sole method of pretransfusion testing. Vox Sang 1992;63:141.
25. Arriaga F, Alvarez C, Llopis F, et al. Incidence and clinical significance of Wright antigen and antibody. In: Abstracts from the ISBT VII European Congress, Paris, 2001:169S.
26. Schonewille H, van Zijl AM, Wijermans PW. The importance of antibodies against low incidence red blood cell antigens in complete and abbreviated crossmatching. Transfusion 2003;43:939-44.